Retinoic acid (RA), the active derivative of vitamin A, is involved in various developmental and homeostatic processes. To define whether certain developmental events are particularly sensitive to a decrease in embryonic RA levels, we generated mice bearing a hypomorphic allele of the RA-synthesizing enzyme Raldh2. The resulting mutant mice, which die perinatally, exhibit the features of the human DiGeorge syndrome (DGS) with heart outflow tract septation defects and anomalies of the aortic arch-derived head and neck arteries, laryngeal-tracheal cartilage defects, and thymus͞parathyroid aplasia or hypoplasia. Analysis of Raldh2 hypomorph embryos reveal selective defects of the posterior (third to sixth) branchial arches, including absence or hypoplasia of the corresponding aortic arches and pharyngeal pouches, and local down-regulation of RA-target genes. Thus, a decreased level of embryonic RA (through genetic and͞or nutritional causes) could represent a major modifier of the expressivity of human 22q11del-associated DiGeorge͞velocardiofacial syndromes and, if severe enough, could on its own lead to the clinical features of the DiGeorge syndrome.
Retinoic acid (RA), the active derivative of vitamin A, is involved in various developmental and homeostatic processes. To define whether certain developmental events are particularly sensitive to a decrease in embryonic RA levels, we generated mice bearing a hypomorphic allele of the RA-synthesizing enzyme Raldh2. The resulting mutant mice, which die perinatally, exhibit the features of the human DiGeorge syndrome (DGS) with heart outflow tract septation defects and anomalies of the aortic arch-derived head and neck arteries, laryngeal-tracheal cartilage defects, and thymus͞parathyroid aplasia or hypoplasia. Analysis of Raldh2 hypomorph embryos reveal selective defects of the posterior (third to sixth) branchial arches, including absence or hypoplasia of the corresponding aortic arches and pharyngeal pouches, and local down-regulation of RA-target genes. Thus, a decreased level of embryonic RA (through genetic and͞or nutritional causes) could represent a major modifier of the expressivity of human 22q11del-associated DiGeorge͞velocardiofacial syndromes and, if severe enough, could on its own lead to the clinical features of the DiGeorge syndrome. R etinoic acid (RA), the active vitamin A (retinol) derivative, is involved in numerous vertebrate developmental processes. RA acts as a ligand for nuclear receptors (RARs), which exist as three distinct isotypes (RAR␣, -␤, and -␥) and bind as heterodimers with retinoid X receptors to regulatory DNA sequences known as RA response elements (RAREs) (reviewed in refs. 1 and 2). All three RARs are expressed during mouse development, either in an almost ubiquitous manner (for RAR␣) or in more complex, tissue-specific patterns (for RAR␤ and -␥; ref. 3 and references therein). Gene-targeting studies have shown that these receptors may function in a redundant manner during development (ref. 4 and references therein). Whereas null mutation for any given receptor leads to viable mice, compound mutations of any receptor pair result in pleiotropic developmental defects that recapitulate the spectrum of abnormalities generated by dietary vitamin A deficiency in rodents (5) .
Two enzymatic reactions convert retinol, which in mammalian embryos is supplied transplacentally from the maternal circulation, into RA. The retinaldehyde (Ral) to RA conversion can be carried out by three members of the aldehyde dehydrogenase family, the retinaldehyde dehydrogenases (RALDH) 1, 2, and 3 (also known as ALDH1A1, -A2, and -A3) (6, 7) . Among these, RALDH2 is expressed from gastrulation onward, and its expression sites correlate with many of the regions that were shown to contain RA during early embryogenesis (8) . Homozygous disruption of the mouse Raldh2 gene is early [around embryonic day (E)10.5] embryonic lethal, because of defects in heart morphogenesis (9, 10) . Abnormal patterning of the hindbrain and altered somitic development are also seen (9, 11) .
It is yet unclear whether certain developmental events are especially sensitive to a decrease, rather than a complete lack, of RA signaling. This is, however, an important issue in the context of human embryology, because situations of decreased function (e.g., through heterozygous mutations of RALDH2 or RAR genes) are likely to occur more frequently than conditions that disrupt RA signaling. To address this question, we took advantage of a murine Raldh2 allele (Raldh2 neo ) that was generated to allow conditional mutagenesis and harbors an intronic neoselectable marker. We show that this allele behaves as a hypomorph, and that the corresponding mutant mice die perinatally. Interestingly, these mice exhibit a limited set of abnormalities that phenocopy the human DiGeorge syndrome (DGS), a relatively frequent birth disorder characterized by heart outflow tract septation defects, abnormal patterning of the aortic arch derivatives, and hypoplasia or aplasia of the thymus and parathyroid glands (12, 13) .
Methods
Gene Targeting. A 15-kb Raldh2 genomic clone was isolated from a mouse 129͞sv genomic library by using a Raldh2 cDNA probe. EcoRI and KpnI restriction sites were generated in introns 3 and 4, respectively, by site-directed mutagenesis. These sites were used to introduce, respectively, a synthetic double-stranded oligonucleotide containing an antisense loxP site and a NsiI restriction site, and a loxP-flanked PGK-neo-poly(A) cassette. The linearized targeting construct was electroporated into embryonic stem (ES) cells, and homologous recombination was identified in 3 of 250 G418-resistant clones by using 5Ј-and 3Ј-flanking probes (see Fig. 1 A) . Raldh2 neo/ϩ ES cells were injected in C57BL͞6 blastocysts, which were reimplanted into CD1 pseudopregnant females to produce chimeric mice. Germline transmission was observed with five of the chimeric males. and Raldh2 neo/Ϫ mutants, respectively. Genotype was assessed by PCR analysis of tail or yolk sac genomic DNA (primer sequences and PCR conditions are available on request). Histological analysis and whole-mount immunohistochemistry were performed as described (14) . Skeletal stainings were performed without removal of internal organs, thus allowing staining of the large arteries. Whole-mount in situ hybridization (ISH) was performed (15) by using plasmids kindly provided by G. Barsh
Results
The Raldh2 neo allele, which was originally generated in ES cells to allow Cre-mediated conditional mutagenesis, contains a floxed (f flanked with loxP sites) PGK-neo selectable marker in the fourth intron and a single loxP site in the third intron (Fig.  1 A) ) littermates ( Fig. 1 B and C) . A similar result was obtained with a fourth exon-specific probe (located upstream of the neo insertion), demonstrating that the decreased ISH signals do not result from lack of transcribed sequences located downstream of the neo insertion ( Fig. 1 B and C Insets) . Immunochemistry analysis using a RALDH2 polyclonal antibody revealed a similar decrease of protein levels in Raldh2 neo/Ϫ mutants ( Fig. 1 D and E) .
To investigate the effect of the Raldh2 neo mutation on embryonic RA levels, Raldh2 neo mice were crossed with an RAreporter transgenic line (16) . The pattern of RARE-lacZ reporter activity was spatially similar to that of Raldh2 transcripts in E9.5 control embryos (compare Fig. 1 phenotypic defects were investigated by dissection of animals collected by Cesarean section at E18.5 or as newborns at P1, whole skeletal staining at E18.5-P1, and histological analysis at E14.5 and E18.5-P1. Most of the mutants recovered at E18.5 or P1 were alive, but they developed signs of cyanosis and suffocation within a few hours. Except for a slightly smaller size, the mutants showed no visible external defect. Lack of septation of the heart outflow tract into aorta and pulmonary trunk (persistent truncus arteriosus, PTA) was seen macroscopically or histologically in all Raldh2 neo/Ϫ mutants ( Fig.  2B and data not shown). A ventricular septal defect was consistently associated (data not shown), as seen in human cases of PTA (18) . No other heart defect was otherwise seen histologically (data not shown). The severity of the outflow tract septation defect appeared to depend on Raldh2 gene dosage, as five of seven Raldh2 (Fig. 2G ). The right subclavian artery (RSA) originated ectopically from the descending aorta, and the left subclavian artery (LSA) and left carotid arteries arose from a common trunk or innominate artery (Fig. 2 F and G) . In WT, the innominate artery gives rise to the RSA and right common carotid artery ( Fig. 2 D and E) . Mutants with a left-sided aortic arch also displayed abnormal patterns of subclavian and carotid arteries ( Fig. 2 H and I) . The innominate artery was often absent, such that the RSA originated directly from the ascending aorta ( the aortic arch (REC and RIC in Fig. 2 F and H) , the innominate artery (LEC and LIC in Fig. 2G ), or at midtracheal (instead of upper cervical) level (REC and RIC in Fig. 2F ; LEC and LIC in Fig. 2G ). One Raldh2 neo/neo mutant exhibited an abnormally high (cervical) aortic arch and an abnormal origin of the RSA, which arose distally as a common stem with the LSA, whereas its carotid arteries arose from a common proximal innominate artery (Fig. 2H ). An ectopic origin of the LSA from the ductus arteriosus was also observed in one Raldh2 neo/neo mutant (data not shown). These defects are likely to result from an abnormal development or remodeling of the embryonic aortic arch system (see below).
Abnormalities of the heart outflow tract and large vessels are the major defects of the human DGS (13) . Other characteristic features of this syndrome are the presence of a shorter trachea, with reduced number of tracheal rings, that may result from deficient blood supply in the fetal cervical region (19) , as well as hypoplasia or aplasia of the thymus and parathyroid glands (12) . A short trachea, with highly abnormal tracheal rings, was characteristic of Raldh2 neo/Ϫ mutants (Fig. 3B) . As seen for the outflow tract septation defects, Raldh2 neo/neo mice displayed a milder version of this phenotype, with slightly reduced cartilage ring numbers (Fig. 3C) . Abnormalities of the laryngeal cartilages were also detected in Raldh2 neo/Ϫ mutants (Fig. 3 D-G , note the abnormal cartilaginous link between the hyoid bone and the thyroid cartilage and the abnormal segmentation of the cricoid cartilage into ring-like structures in E and G, respectively). The body of the hyoid bone and the laryngeal cartilages develop from the mesenchyme of the third and fourth to sixth branchial arches, respectively (18) . No abnormality of more rostrally derived skeletal structures was seen in Raldh2 neo mutants (data not shown). Most of the mutants (9 of 10) displayed aplasia or marked hypoplasia of the thymus (Fig. 3 H and I) . The WT parathyroid glands are embedded within the lateral regions of the thyroid gland (Fig. 3J) . Whereas the thyroid gland was well formed in Raldh2 neo mutants, no parathyroid glands were found at the expected location (Fig. 3K) .
DGS is thought to involve an embryonic defect restricted to the posterior most (third or fourth to sixth) branchial arches and the corresponding pharyngeal pouches (13, 20) . We therefore investigated the embryonic basis of the Raldh2 neo phenotype. At E9.5, Raldh2 neo/Ϫ mutants could be identified by their apparent lack of third branchial arches (e.g., Fig. 4J ). Histological analysis showed well developed first and second arches, whereas the putative third to sixth arch region was very poorly developed ( Fig. 4 A and B) . The second pharyngeal pouch was properly formed. However, whereas more posterior ectodermal clefts were identified, there was no sign of distinct third or fourth pharyngeal pouches (Fig. 4B) . Intracardial ink injections were performed at various developmental stages to visualize the embryonic aortic arch system. At E9.5, such injections labeled the second and third aortic arches in WT embryos (Fig. 4C Inset) . However, no third aortic arches were formed in Raldh2 neo/Ϫ embryos (Fig. 4D Inset) . The third aortic arches became apparent at E10.5 in mutant embryos (data not shown). Whereas distinct fourth and sixth aortic arches were formed at E11.5 in WT (Fig. 4C) , the mutant embryos exhibited a single, enlarged vessel caudal to their third arches (Fig. 4D, A4-6Ј ).
Neural crest cells (NCC) originating from the posterior hindbrain and migrating through the third, fourth, and sixth branchial arches give rise to a cardiac NCC population, which is required for proper septation of the outflow tract (21) . Crabp1 mRNA was used as a molecular marker of migrating NCC in E9.5 WT (Fig.  4E) and Raldh2 neo/Ϫ (Fig. 4F) embryos. A substantial NCC population was present in the posterior branchial region of mutant embryos (Fig. 4F) . However, these cells were not organized in distinct segmental migratory pathways as in WT embryos (Fig. 4E) . In contrast, the migratory pathways of more rostral NCC populations (e.g., toward branchial arches 1 and 2) were unaltered in mutant embryos. Analysis of AP2␣ (22) transcripts and the Wnt1-lacZ transgene (23) at E9.0 also indicated that there was no deficiency in pre-or early migratory NCC in Raldh2 neo/Ϫ mutants (data not shown). Furthermore, a Kreisler-labeled migratory cell population was present in E8.5 Raldh2 neo/Ϫ embryos (data not shown). Interestingly, Kreisler transcripts specifically mark rhombomere 6-derived NCC, which migrate into the third branchial arches in WT embryos.
We also analyzed cranial nerve development in mutant embryos. Antineurofilament staining at E9.5 revealed a normal patterning of the Vth (trigeminal) and VIIth-VIIIth (facialacoustic) cranial nerve ganglia and distal branches, which innervate first and second branchial arch derivatives, respectively (Fig. 4H) . However, the fibers that should contribute to cranial nerves IX (glosso-pharyngeal) and X (vagus) merged in a single bundle and failed to form separate distal ganglia (compare Fig.  4 G and H) . Using c-ret as a molecular marker of the facialacoustic ganglion complex at E10.5, we found very few positive cells posteriorly to the otocyst, at the expected level of the glossopharyngeal and vagal ganglia (data not shown). In addition, Neurogenin2 (ngn2) transcript analysis revealed an abnormal fusion of the second and third epibranchial placodes in E9.5 Raldh2 neo/Ϫ embryos (data not shown). Hence, as seen for migratory NCC, cranial nerve developmental defects are restricted to the postotic branchial region in Raldh2 neo/Ϫ mutants.
The Raldh2 neo aortic arch phenotype (Fig. 4D) is reminiscent of that of Tbx1 Ϫ/Ϫ knockout embryos (24) (25) (26) . We therefore investigated whether Tbx1 expression may be altered in Raldh2 neo/Ϫ embryos. Tbx1 expression was unaffected in the core mesenchyme of the first and second mutant branchial arches (compare Fig. 4 I and J) . Tbx1 mesenchymal expression was detected in the mutant posterior branchial region, which may correspond to the third arch core mesenchymal expression seen in WT embryos (Fig. 4J, arrow) . Tbx1 was also expressed in the mutant posterior pharyngeal endoderm, although its expression seemed somewhat reduced and not as sharply defined as in WT littermates (compare Fig. 4 I and J) . Whether this alteration may be a cause or a consequence of the lack of development of third and fourth pharyngeal pouches is unknown. Hypomorphic mutations of the mouse Fgf8 gene lead to posterior branchial arch defects (27, 28) similar to those seen in mouse models for DGS (24) (25) (26) , and Fgf8 expression is selectively altered in the posterior branchial region of Tbx1 Ϫ/Ϫ mouse mutants (29) . We analyzed Fgf8 expression in E9.5 Raldh2 neo/Ϫ embryos and found that its expression was abnormally low and͞or patchy in both the ectoderm and endoderm of the posterior pharyngeal region (compare Fig. 4 K and L with M and N) .
We have previously reported that Raldh Ϫ/Ϫ null mutants exhibit severe growth and patterning defects of the posterior hindbrain region (11) . Several rhombomeric markers were therefore analyzed in Raldh2 neo/Ϫ embryos. The hindbrain expression patterns of Hoxb1 (Fig. 4 O and Q) , kreisler (Fig. 4 P and R) , and Hoxd4 (data not shown), which mark, respectively, rhombomeres 4, 5͞6, and 7, were not detectably altered in the Raldh2 neo/Ϫ mutants, thus excluding a primary defect of hindbrain growth or patterning.
The Hoxa1 and Hoxb1 homeobox genes are two in vivo RA target genes (30) . When analyzed in Raldh2 neo/Ϫ embryos, expression of both genes seemed to be selectively down-regulated in the posterior branchial arch and foregut region (Fig. 4 S-V) . Expression of both genes in the tail bud region, as well as Hoxb1 expression in rhombomere 4, was similar in WT and mutant embryos (Fig. 4 S-V , see also X and Y). Expression of both genes was altered in both the endodermal and ectodermal layers of the pharyngeal region (Fig. 4 X and Y and data not shown) . Expression of Rar␤, another direct RA-target gene, was also selectively affected in the posterior pharyngeal endoderm and mesoderm, whereas its expression in more rostral pharyngeal areas or in the neural tube was not altered in Raldh2 neo/Ϫ mutants (data not shown).
Discussion
Although the Raldh2 hypomorphic mutation leads to an overall decrease of its mRNA and protein gene products, as well as of the activity of an RA-responsive reporter transgene in the embryo, its phenotypic consequences are strikingly restricted to a subset of tissues whose development requires RA (9, 11) . Most interestingly, the observed defects, which also correspond to a subset of the spectrum of congenital abnormalities resulting from dietary vitamin A deficiency in rats (5) or compound RAR gene knockouts in mice (31) , recapitulate the traits of the DGS, a relatively frequent (1:5,000-1:10,000 live births) human disorder characterized by heart outflow tract septation defects, abnormal patterning of the aortic arch derivatives, and hypoplasia or aplasia of the thymus and parathyroid glands (12, 13) . This syndrome is thought to result from developmental defect(s) arising in the region of the third and fourth branchial arches and the corresponding pharyngeal pouches. Our analysis of Raldh2 neo/Ϫ embryos revealed specific defects of the third to sixth branchial arch region. The observed defects are consistent with those that have been described in cultured mouse embryos that were treated with a synthetic RAR antagonist at early stages of branchial arch formation (32) . Taken all together, our results indicate that cardiac NCC, which do not seem to be initially deficient in Raldh2 neo embryos, are perturbed in their migratory pathways and͞or developmental potential due to severe morphological and molecular defects of the posterior pharyngeal endoderm. We conclude that RA normally synthesized by RALDH2 in the posterior pharyngeal mesoderm (unpublished data) is an important signal to correctly pattern the adjacent endoderm and the cardiac NCC.
In humans, the DGS abnormalities are often associated with additional craniofacial defects such as telecanthus (short palpebral fissures), micrognathia, small and low set ears, and͞or cleft palate. This association, known as velocardiofacial (VCFS) or Shprintzen syndrome (33, 34) , most often (Ϸ90%) results from heterozygous microdeletions on the long arm of chromosome 22 (22q11.2del) (35) (36) (37) . Several groups have recently engineered chromosomal deletions in the murine region homologous to the 22q11.2 human region (38) (39) (40) . Their work led to the conclusion that several genes may be involved in the pathogenesis of the 22q11.2del DGS͞VCFS abnormalities, among which Tbx1 (24, 25, 40) and Crko1 (41) may be two critical determinants. Whereas heterozygous disruption of mouse Tbx1 generates specific defects of the fourth aortic arches (24) and their derivatives (40) , homozygous disruption of these two genes leads to defects along the entire branchial arch region, as well as (in the case of Tbx1) in more anterior skull structures (24, 25) . However, Raldh2 neo/Ϫ mutants did not exhibit any strong alteration of Tbx1 expression, as well as of other genes expressed in the developing arch mesenchyme and endoderm (e.g., HRT1 and dH and, data not shown). Thus, the Raldh2 neo/Ϫ DGS-like syndrome is likely to result from pharyngeal molecular alterations that may be independent (e.g., Hoxa1 and Hoxb1 deficiency, ref. Despite the frequent occurrence of 22q11.2 deletions in patients with DGS͞VCFS features, DGS has long been recognized as an etiologically heterogeneous syndrome (37) , which may involve other genetic loci (such as 10p3) (43, 44) , as well as epigenetic and͞or environmental causes. Our data, which demonstrate that caudal branchial arches are exquisitely sensitive to RA deficiency, indicate that decreased levels of embryonic RA could be one of these causes. Even rather subtle impairments of RA synthetic ability (e.g., through heterozygous mutation of RALDH2) could be potentiated by situations of vitamin A deficiency, resulting from insufficient or imbalanced nutritional intake (e.g., in the case of anorexia). Whereas severe vitamin A deficiency is unlikely to be seen in developed countries, an important risk factor could be embryonic exposure to ethanol, as it may act as a competitive inhibitor of alcohol dehydrogenase(s) that act upstream of RALDH enzymes to catalyze the first step in the conversion of retinol to RA (45) . It is noteworthy that DGS abnormalities have been described in children with clinical evidence of fetal alcohol syndrome (46) . More generally, our study demonstrates that alterations of RA signaling should also be considered as possible modifiers of the DGS͞VCFS phenotypes, including in the case of 22q11 deletion-linked syndromes whose expressivity is highly variable, even within a single family or among monozygotic twins (47) .
